drugset / Trial / NCT04454996

Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen

NCT04454996

RandomizedParallel-groupTriple-blindTreatment

Summary

To clarify the changes of intestinal flora - gut - brain axis in FGIDs patients represented by NERD disharmony of liver and stomach and IBS-D disharmony of liver and spleen, and confirm that the imbalance between intestinal flora and host co-metabolism is the key to the pathogenesis of functional gastrointestinal disease. To reveal the common mechanism of regulating liver and spleen (stomach) in treating FGIDs dynamic disorder and visceral hypersensitivity by regulating intestinal flora - intestine - brain axis disorder.

Timeline

Start
2020-06-25
Primary completion
2021-09-30
Completion
2022-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Chang 'an II Recipe Traditional medicine (herbal / TCM) 1 unknown
Subject Tongjiang granules Traditional medicine (herbal / TCM) 1 unknown